Wilhelm Beier is a German businessman, the chairman of the supervisory board of pharmaceutical company Dermapharm (ETR: DMP). He founded the company in 1991.

Dermapharm, based in Gruenwald near Munich, manufactures generic drugs for maladies ranging from insect bites to fungal diseases and osteoporosis. Beier and his family still own more than 70% of the company.

• Core Company: Dermapharm (Pharmaceutical company).
• Founding: Founded in 1991.
• Ownership: He and his family still own more than 70% of the company.

Wilhelm Beier's career is defined by his success in the pharmaceutical sector and his unique business strategies. His structural achievement is tied to establishing Dermapharm as a manufacturer and distributor of generic drugs.

The company generates nearly half of its revenues from the so-called "parallel trade", which involves arbitraging price differences for drugs between countries. Dermapharm, which went public in 2018, is also expanding into the business of medical marijuana. The company also holds over 40% of one Germany's most popular home shopping television channels.

• Unique Strategy: Nearly half of revenues come from arbitraging price differences for drugs between countries.